Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 11—November 2012
Research

Risk for Travel-associated Legionnaires’ Disease, Europe, 2009

Julien BeautéComments to Author , Phillip Zucs, Birgitta de Jong, and for the European Legionnaires’ Disease Surveillance Network
Author affiliations: European Centre for Disease Prevention and Control, Stockholm, Sweden; European Legionnaires’ Disease Surveillance Network, Stockholm

Main Article

Table 3

Expected risk for Legionnaires’ disease in European travelers to nondomestic destinations in Europe, based on reference data reported by the United Kingdom, the Netherlands, France, and Denmark, Europe, 2009*†

Destination Risk for travelers to destination (cases/million nights) Incidence ratio (95% CI) Total no. cases
Reported Estimated
Greece 1.68 7.2 (4.2–12.2) 34 98
Italy 1.40 6.0 (3.9–9.2) 209 463
Germany 1.19 5.1 (2.9–8.7) 22 353
Portugal 1.06 4.6 (2.1–9.0) 20 44
Austria 1.01 4.4 (2.2–8.2) 20 95
Spain 0.57 2.5 (1.6–3.8) 98 188
France 0.53 2.3 (1.6–3.3) 137 145
Netherlands 0.33 1.4 (0.8–2.4) 21 26
United Kingdom 0.23 1.0 (Ref.) 45 53
Other countries 0.90 3.9 (2.3–6.4) 42 282
Total 0.55 NA 607 1,127

*A case-patient could have a travel history involving >1 country. Ref., referent; NA, not applicable.
†In the United Kingdom, reporting of Legionnaires’ disease became mandatory in 2010.

Main Article

Page created: October 16, 2012
Page updated: October 16, 2012
Page reviewed: October 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external